USPTO serial 79050107
BASILEA
Reviewed by CopyMark Law Group
Reg. 3689485Status 404
- Filing date
- Status date
- Registration date
- Sep 29, 2009
- Examiner
- LEE, JANET H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BASILEA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Evan A. Raynes
Evan A. Raynes Symbus Law Group, LLC1425 K Street, N.W., Suite 350Washington, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anestesiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only | SECTION 71 - CANCELLED | — |
| 042 | research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Basilea Pharmaceutica Deutschland GmbH
- Other trademarks owned by Basilea Pharmaceuticals GmbH
- Other trademarks owned by Basilea Pharmaceutica AG
- Other trademarks owned by Basilea Pharmaceutica AG
- Other trademarks owned by Basilea Pharmaceutica AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named BASILEA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 20, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 9, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 26, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 11, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 11, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jan 6, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 6, 2016 | C71T | CANCELLED SECTION 71 | — |
| Aug 13, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 28, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 2, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 2, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 29, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 29, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 28, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 13, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 13, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 14, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 24, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 11, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 10, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2009 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 3, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| May 7, 2009 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 30, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 30, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 31, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 31, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 31, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2008 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 15, 2008 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 29, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 29, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 28, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 19, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 31, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 31, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 30, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 13, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |